Guardant Health (GH) Short-term Investments (2017 - 2026)

Guardant Health has reported Short-term Investments for 10 years, with the latest figure at $113.5 million in Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $113.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113.5 million (changed N/A YoY) and the FY2025 annual result came in at $823.4 million, up 161.86% from the prior year.
• Short-term Investments retreated to $113.5 million in Q1 2026 per GH's latest filing, from $823.4 million in the prior quarter.
• Over five years, Short-term Investments peaked at $953.8 million in Q2 2023 and troughed at $35.1 million in Q4 2023.
• A 5-year average of $554.9 million and a median of $668.0 million in 2022 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments plunged 95.96% in 2023, then surged 795.91% in 2024.
• Over 5 years, Short-term Investments stood at $869.6 million in 2022, then slumped by 95.96% to $35.1 million in 2023, then soared by 795.91% to $314.4 million in 2024, then surged by 161.86% to $823.4 million in 2025, then sank by 86.22% to $113.5 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $113.5 million, $823.4 million, and $314.4 million for Q1 2026, Q4 2025, and Q4 2024 respectively.